PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) Fundamental Analysis & Valuation

FRA:PAH3 • DE000PAH0038

Current stock price

31.31 EUR
-0.59 (-1.85%)
Last:

This PAH3.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. PAH3.DE Profitability Analysis

1.1 Basic Checks

  • PAH3 had positive earnings in the past year.
  • PAH3 had a positive operating cash flow in the past year.
  • PAH3 had positive earnings in 4 of the past 5 years.
  • PAH3 had a positive operating cash flow in each of the past 5 years.
PAH3.DE Yearly Net Income VS EBIT VS OCF VS FCFPAH3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B -20B

1.2 Ratios

  • With a Return On Assets value of -51.32%, PAH3 is not doing good in the industry: 96.67% of the companies in the same industry are doing better.
  • PAH3 has a worse Return On Equity (-61.54%) than 93.33% of its industry peers.
  • With a decent Return On Invested Capital value of 5.64%, PAH3 is doing good in the industry, outperforming 73.33% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for PAH3 is in line with the industry average of 5.97%.
Industry RankSector Rank
ROA -51.32%
ROE -61.54%
ROIC 5.64%
ROA(3y)-9.78%
ROA(5y)-2.27%
ROE(3y)-12.42%
ROE(5y)-3.83%
ROIC(3y)6.04%
ROIC(5y)6.18%
PAH3.DE Yearly ROA, ROE, ROICPAH3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • With an excellent Operating Margin value of 98.50%, PAH3 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PAH3 has remained more or less at the same level.
  • The Profit Margin and Gross Margin are not available for PAH3 so they could not be analyzed.
Industry RankSector Rank
OM 98.5%
PM (TTM) N/A
GM N/A
OM growth 3Y-0.12%
OM growth 5Y0.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAH3.DE Yearly Profit, Operating, Gross MarginsPAH3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

6

2. PAH3.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PAH3 is creating some value.
  • The number of shares outstanding for PAH3 remains at a similar level compared to 1 year ago.
  • PAH3 has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PAH3 has a worse debt to assets ratio.
PAH3.DE Yearly Shares OutstandingPAH3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
PAH3.DE Yearly Total Debt VS Total AssetsPAH3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • PAH3 has an Altman-Z score of 1.81. This is a bad value and indicates that PAH3 is not financially healthy and even has some risk of bankruptcy.
  • PAH3 has a Altman-Z score of 1.81. This is in the better half of the industry: PAH3 outperforms 76.67% of its industry peers.
  • The Debt to FCF ratio of PAH3 is 9.89, which is on the high side as it means it would take PAH3, 9.89 years of fcf income to pay off all of its debts.
  • PAH3 has a Debt to FCF ratio (9.89) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.19 indicates that PAH3 is not too dependend on debt financing.
  • PAH3 has a Debt to Equity ratio of 0.19. This is amongst the best in the industry. PAH3 outperforms 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 9.89
Altman-Z 1.81
ROIC/WACC0.94
WACC6.02%
PAH3.DE Yearly LT Debt VS Equity VS FCFPAH3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 14.28 indicates that PAH3 has no problem at all paying its short term obligations.
  • PAH3's Current ratio of 14.28 is amongst the best of the industry. PAH3 outperforms 100.00% of its industry peers.
  • PAH3 has a Quick Ratio of 14.28. This indicates that PAH3 is financially healthy and has no problem in meeting its short term obligations.
  • PAH3 has a Quick ratio of 14.28. This is amongst the best in the industry. PAH3 outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 14.28
Quick Ratio 14.28
PAH3.DE Yearly Current Assets VS Current LiabilitesPAH3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. PAH3.DE Growth Analysis

3.1 Past

  • PAH3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.98%, which is quite impressive.
  • Measured over the past years, PAH3 shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.11% on average per year.
  • Looking at the last year, PAH3 shows a very strong growth in Revenue. The Revenue has grown by 74.63%.
  • The Revenue has been growing by 26.12% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)73.98%
EPS 3Y9.34%
EPS 5Y27.11%
EPS Q2Q%N/A
Revenue 1Y (TTM)74.63%
Revenue growth 3Y7.26%
Revenue growth 5Y26.12%
Sales Q2Q%50.34%

3.2 Future

  • Based on estimates for the next years, PAH3 will show a decrease in Earnings Per Share. The EPS will decrease by -5.06% on average per year.
  • The Revenue is expected to decrease by -80.45% on average over the next years. This is quite bad
EPS Next Y18.75%
EPS Next 2Y7.85%
EPS Next 3Y-3.64%
EPS Next 5Y-5.06%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-80.45%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PAH3.DE Yearly Revenue VS EstimatesPAH3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1B 2B 3B 4B 5B
PAH3.DE Yearly EPS VS EstimatesPAH3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

8

4. PAH3.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 2.10, which indicates a rather cheap valuation of PAH3.
  • Based on the Price/Earnings ratio, PAH3 is valued cheaper than 100.00% of the companies in the same industry.
  • PAH3's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.21.
  • PAH3 is valuated cheaply with a Price/Forward Earnings ratio of 1.81.
  • 90.00% of the companies in the same industry are more expensive than PAH3, based on the Price/Forward Earnings ratio.
  • PAH3 is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.1
Fwd PE 1.81
PAH3.DE Price Earnings VS Forward Price EarningsPAH3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PAH3 is valued cheaper than 83.33% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PAH3 is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.8
EV/EBITDA 2.69
PAH3.DE Per share dataPAH3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

  • PAH3's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PAH3's earnings are expected to decrease with -3.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.11
PEG (5Y)0.08
EPS Next 2Y7.85%
EPS Next 3Y-3.64%

5

5. PAH3.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.17%, PAH3 is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 3.96, PAH3 pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, PAH3 pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.17%

5.2 History

  • The dividend of PAH3 has a limited annual growth rate of 2.98%.
Dividend Growth(5Y)2.98%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • PAH3 has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.66%
EPS Next 2Y7.85%
EPS Next 3Y-3.64%
PAH3.DE Yearly Income VS Free CF VS DividendPAH3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B -20B

PAH3.DE Fundamentals: All Metrics, Ratios and Statistics

PORSCHE AUTOMOBIL HLDG-PRF

FRA:PAH3 (4/7/2026, 5:36:15 PM)

31.31

-0.59 (-1.85%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)03-26
Earnings (Next)05-13
Inst Owners18.28%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.79B
Revenue(TTM)4.63B
Net Income(TTM)-21.99B
Analysts70.53
Price Target41.25 (31.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.17%
Yearly Dividend2.56
Dividend Growth(5Y)2.98%
DP-2.66%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)5.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.1
Fwd PE 1.81
P/S 1.38
P/FCF 6.8
P/OCF 6.8
P/B 0.13
P/tB 0.13
EV/EBITDA 2.69
EPS(TTM)14.91
EY47.62%
EPS(NY)17.34
Fwd EY55.39%
FCF(TTM)4.6
FCFY14.71%
OCF(TTM)4.6
OCFY14.71%
SpS22.69
BVpS233.35
TBVpS233.35
PEG (NY)0.11
PEG (5Y)0.08
Graham Number279.79
Profitability
Industry RankSector Rank
ROA -51.32%
ROE -61.54%
ROCE 8.02%
ROIC 5.64%
ROICexc 5.92%
ROICexgc 5.92%
OM 98.5%
PM (TTM) N/A
GM N/A
FCFM 20.29%
ROA(3y)-9.78%
ROA(5y)-2.27%
ROE(3y)-12.42%
ROE(5y)-3.83%
ROIC(3y)6.04%
ROIC(5y)6.18%
ROICexc(3y)6.21%
ROICexc(5y)6.32%
ROICexgc(3y)6.21%
ROICexgc(5y)6.33%
ROCE(3y)8.58%
ROCE(5y)8.78%
ROICexgc growth 3Y-8.5%
ROICexgc growth 5Y-7.91%
ROICexc growth 3Y-8.5%
ROICexc growth 5Y-7.78%
OM growth 3Y-0.12%
OM growth 5Y0.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 9.89
Debt/EBITDA 2
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.37
Cash Conversion 20.59%
Profit Quality N/A
Current Ratio 14.28
Quick Ratio 14.28
Altman-Z 1.81
F-Score3
WACC6.02%
ROIC/WACC0.94
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.98%
EPS 3Y9.34%
EPS 5Y27.11%
EPS Q2Q%N/A
EPS Next Y18.75%
EPS Next 2Y7.85%
EPS Next 3Y-3.64%
EPS Next 5Y-5.06%
Revenue 1Y (TTM)74.63%
Revenue growth 3Y7.26%
Revenue growth 5Y26.12%
Sales Q2Q%50.34%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-80.45%
EBIT growth 1Y-49.42%
EBIT growth 3Y-9.59%
EBIT growth 5Y-5.09%
EBIT Next Year166.08%
EBIT Next 3Y25.59%
EBIT Next 5YN/A
FCF growth 1Y-57.06%
FCF growth 3Y25.04%
FCF growth 5Y14.85%
OCF growth 1Y-57.06%
OCF growth 3Y25.04%
OCF growth 5Y14.66%

PORSCHE AUTOMOBIL HLDG-PRF / PAH3.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to PAH3.DE.


What is the valuation status for PAH3 stock?

ChartMill assigns a valuation rating of 8 / 10 to PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE). This can be considered as Undervalued.


What is the profitability of PAH3 stock?

PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) has a profitability rating of 4 / 10.


How financially healthy is PORSCHE AUTOMOBIL HLDG-PRF?

The financial health rating of PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) is 6 / 10.


What is the expected EPS growth for PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) stock?

The Earnings per Share (EPS) of PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) is expected to grow by 18.75% in the next year.